Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis
C. Meurot(Paris Biotech Santé), Françis Berenbaum(Inserm)
Cited by 129
Related Papers
Diabetes Is an Independent Predictor for Severe Osteoarthritis
|Diabetes Care|2012|334
A Phase <scp>II</scp> Trial of Lutikizumab, an Anti–Interleukin‐1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis
|Arthritis & Rheumatology|2019|209
2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases
|Annals of the Rheumatic Diseases|2022|131